-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DIuAaoOVWsvAVdmIVuJKNriEfeEzMab0KTT9e5wTd5BNpd9WB3hFxC3w3pthrcV8 3cqoxzaxGMNQJd1/p6V+LQ== 0001209191-05-034288.txt : 20050701 0001209191-05-034288.hdr.sgml : 20050701 20050701081704 ACCESSION NUMBER: 0001209191-05-034288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050701 FILED AS OF DATE: 20050701 DATE AS OF CHANGE: 20050701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYDEN BRIAN J CENTRAL INDEX KEY: 0001262224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27854 FILM NUMBER: 05930249 BUSINESS ADDRESS: STREET 1: 1600 ASPEN COMMONS SUITE 300 CITY: MIDDLETON STATE: WI ZIP: 53562 BUSINESS PHONE: 6086627800 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BONE CARE INTERNATIONAL INC CENTRAL INDEX KEY: 0001009405 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 391527471 STATE OF INCORPORATION: WI FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1600 ASPEN COMMONS CITY: MIDDLETON STATE: WI ZIP: 53562 BUSINESS PHONE: 608/662-7800 MAIL ADDRESS: STREET 1: 1600 ASPEN COMMONS CITY: MIDDLETON STATE: WI ZIP: 53562 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-07-01 1 0001009405 BONE CARE INTERNATIONAL INC BCII 0001262224 HAYDEN BRIAN J 1600 ASPEN COMMONS MIDDLETON WI 53562 0 1 0 0 CFO BCII Common Stock 2005-07-01 4 D 0 75001 33.00 D 0 D BCII Restricted Stock Units 2005-07-01 4 D 0 10000 33.00 D 0 D BCII Stock Option Plan 12.50 2005-07-01 4 D 0 75001 20.50 D 2013-08-29 BCII Common Stock 75001 0 D BCII Stock Option Plan 21.12 2005-07-01 4 D 0 10000 11.88 D 2014-06-22 BCII Common Stock 10000 0 D Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per share of BCII Common Stock. Disposed of pursuant to agreement and plan of merger between issuer and Genzyme Corporation and Macbeth Corporation in exchange for a cash payment of $33.00 per BCII Restricted Stock Unit. Each BCII Stock Option became exercisable in full upon consummation of the merger and was cancelled in the merger and was cancelled in the merger in exchange for a cash payment per share subject to the option equal to the difference between the exercise price of the option and $33.00. /s/ Brian J Hayden (Power of Attorney on File) 2005-07-01 -----END PRIVACY-ENHANCED MESSAGE-----